Immunotherapy in Multiple Myeloma.
Gleason C , Catamero DD 
Semin Oncol Nurs.2017 Jul 24 ; ():.
PubMedで表示
Google翻訳で開く
(127view , 0users)
Full Text Sources
To review the use of monoclonal antibodies (mAbs) in the treatment of multiple myeloma (MM) and the management of most common side effects.
PMID: 28751187 [PubMed - as supplied by publisher]
PMID: 28751187 [PubMed - as supplied by publisher]
関連論文
- Monoclonal antibodies - A new era in the treatment of multiple myeloma.
- Daratumumab, Elotuzumab, and the Development of Therapeutic Monoclonal Antibodies in Multiple Myeloma.
- How to Integrate Elotuzumab and Daratumumab Into Therapy for Multiple Myeloma.
- Systematic review and meta-analysis of the efficacy and safety of novel monoclonal antibodies for treatment of relapsed/refractory multiple myeloma.